Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New Dual-Action drug shows promise in lung cancer fight
Disease control Recruiting nowThis study tests a new drug called ivonescimab, which helps the immune system attack cancer and blocks blood vessels that feed tumors. About 60 adults with advanced small cell lung cancer who haven't had treatment will get ivonescimab plus standard chemo. The goal is to find the …
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated May 17, 2026 02:56 UTC
-
Real-World data sought on common lung cancer drug combo
Knowledge-focused Recruiting nowThis study is not testing a new drug but watching how well standard treatments work for people with a specific type of lung cancer (EGFR-mutated NSCLC) in everyday medical practice. About 538 adults with advanced lung cancer will be followed to see how long they live without the …
Sponsor: PrECOG, LLC. • Aim: Knowledge-focused
Last updated May 15, 2026 11:52 UTC